BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Colombel JF, Shin A, Gibson PR. AGA Clinical Practice Update on Functional Gastrointestinal Symptoms in Patients With Inflammatory Bowel Disease: Expert Review. Clin Gastroenterol Hepatol. 2019;17:380-390.e1. [PMID: 30099108 DOI: 10.1016/j.cgh.2018.08.001] [Cited by in Crossref: 42] [Cited by in F6Publishing: 43] [Article Influence: 10.5] [Reference Citation Analysis]
Number Citing Articles
1 Scarlata K, Haller E. Nutrition Tools for the Practicing Gastroenterologist. Gastroenterol Clin North Am 2021;50:1-13. [PMID: 33518156 DOI: 10.1016/j.gtc.2020.10.011] [Reference Citation Analysis]
2 Tuck CJ, Caminero A, Jiménez Vargas NN, Soltys CL, Jaramillo Polanco JO, Lopez Lopez CD, Constante M, Lourenssen SR, Verdu EF, Muir JG, Lomax AE, Reed DE, Vanner SJ. The impact of dietary fermentable carbohydrates on a postinflammatory model of irritable bowel syndrome. Neurogastroenterol Motil 2019;31:e13675. [PMID: 31290223 DOI: 10.1111/nmo.13675] [Cited by in Crossref: 5] [Cited by in F6Publishing: 3] [Article Influence: 1.7] [Reference Citation Analysis]
3 Lee JY, Cevallos SA, Byndloss MX, Tiffany CR, Olsan EE, Butler BP, Young BM, Rogers AWL, Nguyen H, Kim K, Choi SW, Bae E, Lee JH, Min UG, Lee DC, Bäumler AJ. High-Fat Diet and Antibiotics Cooperatively Impair Mitochondrial Bioenergetics to Trigger Dysbiosis that Exacerbates Pre-inflammatory Bowel Disease. Cell Host Microbe 2020;28:273-284.e6. [PMID: 32668218 DOI: 10.1016/j.chom.2020.06.001] [Cited by in Crossref: 17] [Cited by in F6Publishing: 14] [Article Influence: 8.5] [Reference Citation Analysis]
4 He P, Yu L, Tian F, Zhang H, Chen W, Zhai Q. Dietary Patterns and Gut Microbiota: the Crucial Actors in Inflammatory Bowel Disease. Adv Nutr 2022:nmac029. [PMID: 35348593 DOI: 10.1093/advances/nmac029] [Reference Citation Analysis]
5 Weber AT, Shah ND, Sauk J, Limketkai BN. Popular Diet Trends for Inflammatory Bowel Diseases: Claims and Evidence. Curr Treat Options Gastroenterol 2019;17:564-76. [PMID: 31705371 DOI: 10.1007/s11938-019-00248-z] [Cited by in Crossref: 9] [Cited by in F6Publishing: 9] [Article Influence: 3.0] [Reference Citation Analysis]
6 Quigley EMM. Nutraceuticals as modulators of gut microbiota: Role in therapy. Br J Pharmacol 2020;177:1351-62. [PMID: 31659751 DOI: 10.1111/bph.14902] [Cited by in Crossref: 5] [Cited by in F6Publishing: 6] [Article Influence: 2.5] [Reference Citation Analysis]
7 Szałwińska P, Włodarczyk J, Spinelli A, Fichna J, Włodarczyk M. IBS-Symptoms in IBD Patients-Manifestation of Concomitant or Different Entities. J Clin Med 2020;10:E31. [PMID: 33374388 DOI: 10.3390/jcm10010031] [Cited by in Crossref: 3] [Cited by in F6Publishing: 4] [Article Influence: 1.5] [Reference Citation Analysis]
8 Yelencich E, Truong E, Widaman AM, Pignotti G, Yang L, Jeon Y, Weber AT, Shah R, Smith J, Sauk JS, Limketkai BN. Avoidant Restrictive Food Intake Disorder Prevalent Among Patients With Inflammatory Bowel Disease. Clin Gastroenterol Hepatol 2021:S1542-3565(21)00864-8. [PMID: 34389486 DOI: 10.1016/j.cgh.2021.08.009] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
9 Dal Buono A, Roda G, Argollo M, Zacharopoulou E, Peyrin-Biroulet L, Danese S. Treat to target or 'treat to clear' in inflammatory bowel diseases: one step further? Expert Rev Gastroenterol Hepatol 2020;14:807-17. [PMID: 32762582 DOI: 10.1080/17474124.2020.1804361] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 1.5] [Reference Citation Analysis]
10 Tetangco EP, Stein AC. Medical Treatment of Intestinal Crohn's disease. Seminars in Colon and Rectal Surgery 2022. [DOI: 10.1016/j.scrs.2022.100862] [Reference Citation Analysis]
11 Hu S, Chen Y, Chen Y, Wang C. Depression and Anxiety Disorders in Patients With Inflammatory Bowel Disease. Front Psychiatry 2021;12:714057. [PMID: 34690829 DOI: 10.3389/fpsyt.2021.714057] [Reference Citation Analysis]
12 Serrano-moreno C, Brox-torrecilla N, Arhip L, Romero I, Morales Á, Carrascal ML, Cuerda C, Motilla M, Camblor M, Velasco C, Bretón I. Diets for inflammatory bowel disease: What do we know so far? Eur J Clin Nutr. [DOI: 10.1038/s41430-021-01051-9] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
13 Drewes AM, Olesen AE, Farmer AD, Szigethy E, Rebours V, Olesen SS. Gastrointestinal pain. Nat Rev Dis Primers. 2020;6:1. [PMID: 31907359 DOI: 10.1038/s41572-019-0135-7] [Cited by in Crossref: 32] [Cited by in F6Publishing: 26] [Article Influence: 16.0] [Reference Citation Analysis]
14 Rodríguez-Lago I, Zabana Y, Barreiro-de Acosta M. Diagnosis and natural history of preclinical and early inflammatory bowel disease. Ann Gastroenterol 2020;33:443-52. [PMID: 32879589 DOI: 10.20524/aog.2020.0508] [Cited by in Crossref: 1] [Article Influence: 0.5] [Reference Citation Analysis]
15 Vasant DH, Ford AC. Functional gastrointestinal disorders in inflammatory bowel disease: Time for a paradigm shift? World J Gastroenterol 2020; 26(26): 3712-3719 [PMID: 32774052 DOI: 10.3748/wjg.v26.i26.3712] [Cited by in CrossRef: 2] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
16 Sweeney L, Moss-Morris R, Czuber-Dochan W, Norton C. Pain management in inflammatory bowel disease: feasibility of an online therapist-supported CBT-based self-management intervention. Pilot Feasibility Stud 2021;7:95. [PMID: 33863398 DOI: 10.1186/s40814-021-00829-9] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
17 Dal Buono A, Roda G, Argollo M, Paridaens K, Peyrin-Biroulet L, Danese S. 'Treat to Target' in Mild to Moderate Ulcerative Colitis: Evidence to Support this Strategy. Curr Drug Targets 2021;22:117-25. [PMID: 32718289 DOI: 10.2174/1389450121666200727120305] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
18 Limdi JK. Editorial commentary on the Indian Journal of Gastroenterology—January–February 2022. Indian J Gastroenterol. [DOI: 10.1007/s12664-022-01240-9] [Reference Citation Analysis]
19 Kunovský L, Dítě P, Jabandžiev P, Eid M, Poredská K, Vaculová J, Sochorová D, Janeček P, Tesaříková P, Blaho M, Trna J, Hlavsa J, Kala Z. Causes of Exocrine Pancreatic Insufficiency Other Than Chronic Pancreatitis. J Clin Med 2021;10:5779. [PMID: 34945075 DOI: 10.3390/jcm10245779] [Reference Citation Analysis]
20 Tran LC, Bridoux-Henno L, Gastineau S, Dabadie A, Carré E, Hugot JP, Martinez-Vinson C, Mosca A, Coopman S, Lamireau T, Enaud R, Clouzeau H, Bertrand V, Pigneur B, Ruemmele F, Degas V, Breton A, Mas E, Lacotte É, Chaillou-Legault E, Caron N, Languepin J, Willot S, Bouazza A, Spyckerelle C, Dimitrov G, Thomassin N, Djeddi D, Vanrenterghem A, Grandjean C, Viala J, Dupont-Lucas C. Functional abdominal pain disorders and patient- and parent- reported outcomes in children with inflammatory bowel disease in remission. Dig Liver Dis 2021:S1590-8658(21)00308-X. [PMID: 34187767 DOI: 10.1016/j.dld.2021.05.034] [Reference Citation Analysis]
21 Evidence-Based Medicine Group. [Clinical guidelines for the diagnosis and treatment of neonatal necrotizing enterocolitis (2020)].Zhongguo Dang Dai Er Ke Za Zhi. 2021;23:1-11. [PMID: 33476530 DOI: 10.7499/j.issn.1008-8830.2011145] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
22 Weaver E, Szigethy E. Managing Pain and Psychosocial Care in IBD: a Primer for the Practicing Gastroenterologist. Curr Gastroenterol Rep 2020;22:20. [PMID: 32185521 DOI: 10.1007/s11894-020-0757-7] [Cited by in Crossref: 7] [Cited by in F6Publishing: 6] [Article Influence: 3.5] [Reference Citation Analysis]
23 Barros LL, Farias AQ, Rezaie A. Gastrointestinal motility and absorptive disorders in patients with inflammatory bowel diseases: Prevalence, diagnosis and treatment. World J Gastroenterol 2019; 25(31): 4414-4426 [PMID: 31496621 DOI: 10.3748/wjg.v25.i31.4414] [Cited by in CrossRef: 23] [Cited by in F6Publishing: 19] [Article Influence: 7.7] [Reference Citation Analysis]
24 Walker CH, Gaidos JKJ. Beyond pregnancy, women's health in inflammatory bowel disease. Curr Opin Gastroenterol 2019;35:288-95. [PMID: 33216483 DOI: 10.1097/MOG.0000000000000552] [Reference Citation Analysis]
25 Person H, Keefer L. Brain-Gut Therapies for Pediatric Functional Gastrointestinal Disorders and Inflammatory Bowel Disease. Curr Gastroenterol Rep 2019;21:12. [PMID: 30868282 DOI: 10.1007/s11894-019-0683-8] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 1.3] [Reference Citation Analysis]
26 Colombel JF, Shin A, Gibson PR. Reply. Clin Gastroenterol Hepatol 2019;17:573-4. [PMID: 30678842 DOI: 10.1016/j.cgh.2018.08.073] [Reference Citation Analysis]
27 Peng Z, Yi J, Liu X. A Low-FODMAP Diet Provides Benefits for Functional Gastrointestinal Symptoms but Not for Improving Stool Consistency and Mucosal Inflammation in IBD: A Systematic Review and Meta-Analysis. Nutrients 2022;14:2072. [DOI: 10.3390/nu14102072] [Reference Citation Analysis]
28 Pesce M, Cargiolli M, Cassarano S, Polese B, De Conno B, Aurino L, Mancino N, Sarnelli G. Diet and functional dyspepsia: Clinical correlates and therapeutic perspectives. World J Gastroenterol 2020; 26(5): 456-465 [PMID: 32089623 DOI: 10.3748/wjg.v26.i5.456] [Cited by in CrossRef: 9] [Cited by in F6Publishing: 6] [Article Influence: 4.5] [Reference Citation Analysis]
29 Desmarais A, Smiddy S, Reddy S, El-Dallal M, Erlich J, Feuerstein JD. Evidence supporting the benefits of marijuana for Crohn's disease and ulcerative colitis is extremely limited: a meta-analysis of the literature. Ann Gastroenterol 2020;33:495-9. [PMID: 32879596 DOI: 10.20524/aog.2020.0516] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
30 Elia JR, Beck KR. The Importance of Physical Activity and Structured Exercise Distinction and Analysis-Response to "Physical Activity in Patients with Inflammatory Bowel Disease: A Narrative Review". Inflamm Bowel Dis 2021:izab323. [PMID: 34922351 DOI: 10.1093/ibd/izab323] [Reference Citation Analysis]
31 Kamp K, Dudley-Brown S, Heitkemper M, Wyatt G, Given B. Symptoms among emerging adults with inflammatory bowel disease: a descriptive study. Res Nurs Health 2020;43:48-55. [PMID: 31599462 DOI: 10.1002/nur.21985] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.7] [Reference Citation Analysis]
32 Papada E, Amerikanou C, Forbes A, Kaliora AC. Adherence to Mediterranean diet in Crohn's disease. Eur J Nutr 2020;59:1115-21. [PMID: 31006053 DOI: 10.1007/s00394-019-01972-z] [Cited by in Crossref: 14] [Cited by in F6Publishing: 11] [Article Influence: 4.7] [Reference Citation Analysis]
33 Fairbrass KM, Selinger CP, Gracie DJ, Ford AC. Prevalence and impact of Rome IV versus Rome III irritable bowel syndrome in patients with inflammatory bowel disease. Neurogastroenterol Motil 2021;:e14256. [PMID: 34472157 DOI: 10.1111/nmo.14256] [Reference Citation Analysis]
34 Fitzpatrick JA, Melton SL, Yao CK, Gibson PR, Halmos EP. Dietary management of adults with IBD - the emerging role of dietary therapy. Nat Rev Gastroenterol Hepatol 2022. [PMID: 35577903 DOI: 10.1038/s41575-022-00619-5] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 2.0] [Reference Citation Analysis]
35 Wong ECL, Dulai PS, Marshall JK, Jairath V, Reinisch W, Narula N. Resolution of dominant patient-reported outcome at end of induction predicts clinical and endoscopic remission in Crohn's disease. Aliment Pharmacol Ther 2022. [PMID: 35166396 DOI: 10.1111/apt.16805] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
36 Tocia C, Dumitru IM, Alexandrescu L, Petcu LC, Dumitru E. Does rifaximin offer any promise in Crohn's disease in remission and concurrent irritable bowel syndrome-like symptoms? Medicine (Baltimore) 2021;100:e24059. [PMID: 33429768 DOI: 10.1097/MD.0000000000024059] [Reference Citation Analysis]
37 Morton H, Pedley KC, Stewart RJC, Coad J. Inflammatory Bowel Disease: Are Symptoms and Diet Linked? Nutrients 2020;12:E2975. [PMID: 33003341 DOI: 10.3390/nu12102975] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 1.5] [Reference Citation Analysis]
38 Sweeney L, Windgassen S, Artom M, Norton C, Fawson S, Moss-Morris R. A Novel Digital Self-management Intervention for Symptoms of Fatigue, Pain, and Urgency in Inflammatory Bowel Disease: Describing the Process of Development. JMIR Form Res 2022;6:e33001. [PMID: 35583924 DOI: 10.2196/33001] [Reference Citation Analysis]
39 Kosmidou M, Karavasili NT, Saridi M, Skamnelos A, Kavvadias A, Batistatou A, Gartzonika KG, Tsiara S, Katsanos KH, Christodoulou DK. Clostridium Difficile Infection in Patients Impact Suspected Cytomegalovirus Infection in Patients with Inflammatory Bowel Disease. Mater Sociomed 2020;32:41-5. [PMID: 32410890 DOI: 10.5455/msm.2020.32.41-45] [Reference Citation Analysis]
40 Losurdo G, Salvatore D'Abramo F, Indellicati G, Lillo C, Ierardi E, Di Leo A. The Influence of Small Intestinal Bacterial Overgrowth in Digestive and Extra-Intestinal Disorders. Int J Mol Sci 2020;21:E3531. [PMID: 32429454 DOI: 10.3390/ijms21103531] [Cited by in Crossref: 7] [Cited by in F6Publishing: 5] [Article Influence: 3.5] [Reference Citation Analysis]
41 Pérez de Arce E, Quera R, Beltrán CJ, Madrid AM, Nos P. Irritable Bowel Syndrome in Inflammatory Bowel Disease. Synergy in alterations of the gut-brain axis? Gastroenterol Hepatol 2021:S0210-5705(21)00143-6. [PMID: 34023477 DOI: 10.1016/j.gastrohep.2021.02.022] [Reference Citation Analysis]
42 Liu S, Zhao W, Lan P, Mou X. The microbiome in inflammatory bowel diseases: from pathogenesis to therapy. Protein Cell 2021;12:331-45. [PMID: 32601832 DOI: 10.1007/s13238-020-00745-3] [Cited by in Crossref: 26] [Cited by in F6Publishing: 23] [Article Influence: 13.0] [Reference Citation Analysis]
43 Gracie DJ, Ford AC. Functional Gastrointestinal Symptoms in Inflammatory Bowel Disease: Rising to the Challenge. Clin Gastroenterol Hepatol. 2019;17:572-573. [PMID: 30678841 DOI: 10.1016/j.cgh.2018.08.039] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
44 Bellini M, Tonarelli S, Nagy AG, Pancetti A, Costa F, Ricchiuti A, de Bortoli N, Mosca M, Marchi S, Rossi A. Low FODMAP Diet: Evidence, Doubts, and Hopes. Nutrients 2020;12:E148. [PMID: 31947991 DOI: 10.3390/nu12010148] [Cited by in Crossref: 24] [Cited by in F6Publishing: 17] [Article Influence: 12.0] [Reference Citation Analysis]
45 Ungaro R, Colombel JF, Lissoos T, Peyrin-Biroulet L. A Treat-to-Target Update in Ulcerative Colitis: A Systematic Review. Am J Gastroenterol. 2019;114:874-883. [PMID: 30908297 DOI: 10.14309/ajg.0000000000000183] [Cited by in Crossref: 67] [Cited by in F6Publishing: 57] [Article Influence: 33.5] [Reference Citation Analysis]
46 Castro F, de Souza HSP. Dietary Composition and Effects in Inflammatory Bowel Disease. Nutrients 2019;11:E1398. [PMID: 31234325 DOI: 10.3390/nu11061398] [Cited by in Crossref: 18] [Cited by in F6Publishing: 16] [Article Influence: 6.0] [Reference Citation Analysis]
47 Furfaro F, Dal Buono A, Allocca M, D'Amico F, Zilli A, Gabbiadini R, Danese S. Bowel Ultrasound in Inflammatory Bowel Disease: How Far in the Grayscale? Life (Basel) 2021;11:649. [PMID: 34357022 DOI: 10.3390/life11070649] [Reference Citation Analysis]
48 Jordan A, Maraj B, Kinnucan J. Is it a Flare? Acute Appendicitis in Ulcerative Colitis Patient Found on Routine Screening Colonoscopy. Inflamm Bowel Dis 2022:izac112. [PMID: 35700277 DOI: 10.1093/ibd/izac112] [Reference Citation Analysis]
49 Hsieh M, Hsu W, Wang J, Wang Y, Hu H, Chang W, Chen C, Wu D, Kuo F, Su W. Nutritional and dietary strategy in the clinical care of inflammatory bowel disease. Journal of the Formosan Medical Association 2020;119:1742-9. [DOI: 10.1016/j.jfma.2019.09.005] [Cited by in Crossref: 6] [Cited by in F6Publishing: 3] [Article Influence: 3.0] [Reference Citation Analysis]
50 Scarlata K, Catsos P, Smith J. From a Dietitian's Perspective, Diets for Irritable Bowel Syndrome Are Not One Size Fits All. Clin Gastroenterol Hepatol 2020;18:543-5. [PMID: 31437487 DOI: 10.1016/j.cgh.2019.08.018] [Cited by in Crossref: 9] [Cited by in F6Publishing: 9] [Article Influence: 3.0] [Reference Citation Analysis]
51 Huang X, Ai F, Ji C, Tu P, Gao Y, Wu Y, Yan F, Yu T. A Rapid Screening Method of Candidate Probiotics for Inflammatory Bowel Diseases and the Anti-inflammatory Effect of the Selected Strain Bacillus smithii XY1. Front Microbiol 2021;12:760385. [PMID: 34975786 DOI: 10.3389/fmicb.2021.760385] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 3.0] [Reference Citation Analysis]
52 Bassotti G, Antonelli E, Villanacci V, Nascimbeni R, Dore MP, Pes GM, Maconi G. Abnormal gut motility in inflammatory bowel disease: an update. Tech Coloproctol 2020;24:275-82. [PMID: 32062797 DOI: 10.1007/s10151-020-02168-y] [Cited by in Crossref: 3] [Cited by in F6Publishing: 5] [Article Influence: 1.5] [Reference Citation Analysis]
53 Ratajczak AE, Szymczak-Tomczak A, Skrzypczak-Zielińska M, Rychter AM, Zawada A, Dobrowolska A, Krela-Kaźmierczak I. Vitamin C Deficiency and the Risk of Osteoporosis in Patients with an Inflammatory Bowel Disease. Nutrients 2020;12:E2263. [PMID: 32751086 DOI: 10.3390/nu12082263] [Cited by in Crossref: 3] [Cited by in F6Publishing: 1] [Article Influence: 1.5] [Reference Citation Analysis]
54 Uno Y. Hypothesis: Mechanism of irritable bowel syndrome in inflammatory bowel disease. Med Hypotheses 2019;132:109324. [PMID: 31421429 DOI: 10.1016/j.mehy.2019.109324] [Cited by in Crossref: 6] [Cited by in F6Publishing: 4] [Article Influence: 2.0] [Reference Citation Analysis]
55 Khera AJ, Chase JW, Stillman BC, Salzberg M, Thompson AJV, Basnayake C, Wilson-o’brien A, Kamm MA. Pelvic floor behavioral treatment for fecal incontinence and constipation in quiescent inflammatory bowel disease. Scandinavian Journal of Gastroenterology. [DOI: 10.1080/00365521.2022.2039280] [Reference Citation Analysis]
56 Sasson AN, Ananthakrishnan AN, Raman M. Diet in Treatment of Inflammatory Bowel Diseases. Clin Gastroenterol Hepatol 2021;19:425-435.e3. [PMID: 31812656 DOI: 10.1016/j.cgh.2019.11.054] [Cited by in Crossref: 6] [Cited by in F6Publishing: 7] [Article Influence: 2.0] [Reference Citation Analysis]
57 Shao HQ, Tan ZJ. Microbiota-targeted therapeutics in gastrointestinal diseases. Shijie Huaren Xiaohua Zazhi 2021; 29(15): 841-848 [DOI: 10.11569/wcjd.v29.i15.841] [Reference Citation Analysis]